Emerging role of RUNX3 in the regulation of tumor microenvironment

키워드

참고문헌 (96)

1. Klemm F, "Microenvironmental regulation of therapeutic response in cancer", Cell Biol, 25, pp.198~213 (2015)
2. Balkwill FR, "The tumor microenvironment at a glance", J Cell Sci, 125, pp.5591~5596 (2012)[DOI]
3. Hockel M, "Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects", J Natl Cancer Inst, 93, pp.266~276 (2001)[DOI]
4. Ito Y, "Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2", CBF, 1999, pp.4, 685~696
5. Ito Y, "RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes", Adv Cancer Res, 99, pp.33~76 (2008)
6. Kundu M, "Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma", Blood, 106, pp.3621~3624 (2005)[DOI]
7. Ito Y, "Oncogenic potential of the RUNX gene family: 'overview'", Oncogene, 23, pp.4198~4208 (2004)[DOI]
8. Leong DT, "Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility", Cancer Res, 12, pp.R89~ (2010)[DOI]
9. Woolf E, "Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis", Proc Natl Acad Sci U S A, 100, pp.7731~7736 (2003)[DOI]
10. Levanon D, "The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons", EMBO J, 21, pp.3454~3463 (2002)[DOI]
11. Bae SC, "Tumor suppressor activity of RUNX3", Oncogene, 23, pp.4336~4340 (2004)[DOI]
12. Chen F, "RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma", PLoS One, 8, pp.e56241~ (2013)[DOI]
13. Chen F, "Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer", PLoS One, 9, pp.e86917~ (2014)[DOI]
14. Chuang LS, "RUNX3 is multifunctional in carcinogenesis of multiple solid tumors", Oncogene, 29, pp.2605~2615 (2010)[DOI]
15. Kim HJ, "Loss of RUNX3 expression promotes cancerassociated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer", J Pathol, 237, pp.520~531 (2015)[DOI]
16. Li QL, "Causal relationship between the loss of RUNX3 expression and gastric cancer", Cell, 109, pp.113~124 (2002)[DOI]
17. Kudo Y, "Oncogenic role of RUNX3 in head and neck cancer", J Cell Biochem, 112, pp.387~393 (2011)[DOI]
18. Lee CW, "RUNX3 functions as an oncogene in ovarian cancer", Gynecol Oncol, 122, pp.410~417 (2011)[DOI]
19. Park J, "Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma", Oncotarget, 8, pp.9079~9092 (2017)
20. Inoue K, "Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons", Nat Neurosci, 5, pp.946~954 (2002)[DOI]
21. Lau QC, "RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer", Cancer Res, 66, pp.6512~6520 (2006)[DOI]
22. Ito K, "RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization", Cancer Res, 65, pp.7743~7750 (2005)[DOI]
23. Li QL, "Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer", Biochem Biophys Res Commun, 314, pp.223~228 (2004)[DOI]
24. Kim WJ, "RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors", Cancer Res, 65, pp.9347~9354 (2005)[DOI]
25. Zhang X, "Runx3 inhibits melanoma cell migration through regulation of cell shape change", Cell Biol International, 41, pp.1048~1055 (2017)[DOI]
26. Cameron ER, "The Runx genes: lineage-specific oncogenes and tumor suppressors", Oncogene, 23, pp.4308~4314 (2004)[DOI]
27. Salto-Tellez M, "RUNX3 protein is overexpressed in human basal cell carcinomas", Oncogene, 25, pp.7646~7649 (2006)[DOI]
28. Tsunematsu T, "RUNX3 has an oncogenic role in head and neck cancer", PLoS One, 4, pp.e5892~ (2009)[DOI]
29. Bloe KL, "RUNX3 facilitates growth of Ewing sarcoma cells", J Cell Physiol, 229, pp.2049~2056 (2014)[DOI]
30. Hanahan D, "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)[DOI]
31. Hanahan D, "Hallmarks of cancer: the next generation", Cell, 144, pp.646~674 (2011)[DOI]
32. Quail DF, "Microenvironmental regulation of tumor progression and metastasis", Nat Med, 19, pp.1423~1437 (2013)[DOI]
33. Hanahan D, "Accessories to the crime: functions of cells recruited to the tumor microenvironment", Cancer Cell, 21, pp.309~322 (2012)[DOI]
34. Weber CE, "The tumor microenvironment", Surg Oncol, 21, pp.172~177 (2012)[DOI]
35. Blagosklonny MV, "Antiangiogenic therapy and tumor progression", Cancer Cell, 5, pp.13~17 (2004)[DOI]
36. Semenza GL, "Hypoxia, clonal selection, and the role of HIF-1 in tumor progression", Crit Rev Biochem Mol Biol, 35, pp.71~103 (2000)[DOI]
37. Qian BZ, "Macrophage diversity enhances tumor progression and metastasis", Cell, 141, pp.39~51 (2010)[DOI]
38. Condeelis J, "Macrophages: obligate partners for tumor cell migration, invasion, and metastasis", Cell, 124, pp.263~266 (2006)[DOI]
39. Murdoch C, "Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues", Blood, 104, pp.2224~2234 (2004)[DOI]
40. Grivennikov SI, "Immunity, inflammation, and cancer", Cell, 140, pp.883~899 (2010)[DOI]
41. Chuang LS, "RUNX family: Regulation and diversification of roles through interacting proteins", Int J Cancer, 132, pp.1260~1271 (2013)[DOI]
42. Ito Y, "The RUNX family: developmental regulators in cancer", Nat Rev Cancer, 15, pp.81~95 (2015)[DOI]
43. Lotem J, "Runx3 at the interface of immunity, inflammation and cancer", Biochim Biophys Acta, 1855, pp.131~143 (2015)
44. Afaloniati H, "Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators", Exp Cell Res, 361, pp.257~264 (2017)[DOI]
45. Le XF, "Regulation of AML2", CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway, 1999, pp.274, 21651~21658
46. Kalev-Zylinska ML, "Runx3 is required for hematopoietic development in zebrafish", Dev Dyn, 228, pp.323~336 (2003)[DOI]
47. Facciabene A, "T-regulatory cells: key players in tumor immune escape and angiogenesis", Cancer Res, 72, pp.2162~2171 (2012)[DOI]
48. Hossain DM, "MEK inhibition prevents tumour-shed transforming growth factor-beta-induced T-regulatory cell augmentation in tumour milieu", Immunology, 144, pp.561~573 (2015)[DOI]
49. Dinesh RK, "CD8+ Tregs in lupus, autoimmunity, and beyond", Autoimm Rev, 9, pp.560~568 (2010)[DOI]
50. Chakraborty S, "Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8(+) Treg cells", Sci Rep, 7, pp.1628~ (2017)[DOI]
51. Egawa T, "The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells", J Exp Med, 204, pp.1945~1957 (2007)[DOI]
52. Cruz-Guilloty F, "Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs", J Exp Med, 206, pp.51~59 (2009)[DOI]
53. Li Y, "Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma", Tumour Biol, 35, pp.12235~12244 (2014)[DOI]
54. Massague J, "TGFbeta in Cancer", Cell, 134, pp.215~230 (2008)[DOI]
55. Krishnan V, "TGF-beta promotes genomic instability after loss of RUNX3", Cancer Res, 78, pp.88~102 (2018)[DOI]
56. Voon DC, "The RUNX complex: reaching beyond haematopoiesis into immunity", Immunology, 146, pp.523~536 (2015)[DOI]
57. Mei PJ, "RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration", J Cancer Res Clin Oncol, 137, pp.1823~1830 (2011)[DOI]
58. Kim BR, "RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer", Oncol Rep, 36, pp.2601~2608 (2016)[DOI]
59. Cheng HC, "Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer", Carcinogenesis, 34, pp.2452~2459 (2013)[DOI]
60. Sanchez-Martin L, "The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression", Blood, 117, pp.88~97 (2011)[DOI]
61. Horikawa N, "Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells", Clin Cancer Res, 23, pp.587~599 (2017)[DOI]
62. Oussa NA, "VEGF Requires the Receptor NRP-1 To Inhibit Lipopolysaccharide-Dependent Dendritic Cell Maturation", J Immunol, 197, pp.3927~3935 (2016)[DOI]
63. Peng Z, "RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer", Clin Cancer Res, 12, pp.6386~6394 (2006)[DOI]
64. Gordan JD, "HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation", Cancer Cell, 12, pp.108~113 (2007)[DOI]
65. Simon MC, "The role of oxygen availability in embryonic development and stem cell function", Nat Rev Mol Cell Biol, 9, pp.285~296 (2008)[DOI]
66. Lin Q, "Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics", Cancer Biol Ther, 9, pp.949~956 (2010)[DOI]
67. Lee SH, "Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells", Oncogene, 28, pp.184~194 (2009)[DOI]
68. Chen H, "Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells", Cancer Res, 66, pp.9009~9016 (2006)[DOI]
69. Chen MW, "H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM", Cancer Res, 70, pp.7830~7840 (2010)[DOI]
70. Liu S, "G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma", Oncotarget, 6, pp.6887~6901 (2015)
71. Dong C, "G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer", J Clin Invest, 122, pp.1469~1486 (2012)[DOI]
72. Yuan Y, "Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells", Cell Death Dis, 4, pp.e690~ (2013)[DOI]
73. Kim MS, "Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes", Nat Med, 7, pp.437~443 (2001)[DOI]
74. Iwatani K, "Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction", Biochem Biophys Res Commun, 400, pp.426~431 (2010)[DOI]
75. Lee YS, "Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma", Cancer Cell, 24, pp.603~616 (2013)[DOI]
76. Huang C, "Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment", Biochem Pharmacol, 73, pp.990~1000 (2007)[DOI]
77. Shio S, "Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis", Cancer Sci, 102, pp.776~783 (2011)[DOI]
78. He L, "MicroRNAs: small RNAs with a big role in gene regulation", Nat Rev Genetics, 5, pp.522~531 (2004)[DOI]
79. Kulshreshtha R, "A microRNA component of the hypoxic response", Cell Death Differ, 15, pp.667~671 (2008)[DOI]
80. Nicoloso MS, "MicroRNAs--the micro steering wheel of tumour metastases", Nat Rev Cancer, 9, pp.293~302 (2009)[DOI]
81. Wentz-Hunter KK, "The Role of miRNAs as Key Regulators in the Neoplastic Microenvironment", Mol Biol Int, 2011, pp.839872~ (2011)
82. Paudel D, "MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer", Gene, 586, pp.48~55 (2016)[DOI]
83. Lee SH, "Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells", Oncotarget, 6, pp.33269~33278 (2015)
84. Pande S, "Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes", J Cell Phys, 218, pp.473~479 (2009)[DOI]
85. Kumar A, "Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions", Oncogene, 35, pp.4857~4865 (2016)[DOI]
86. Zhu X, "Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma", J Exp Clin Cancer Res, 33, pp.114~ (2014)[DOI]
87. Tsang YH, "Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome- mediated degradation", Oncogene, 29, pp.5643~5650 (2010)[DOI]
88. Kumar V, "Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment", Immunology, 143, pp.512~519 (2014)[DOI]
89. Lee SH, "RUNX3 inhibits hypoxia-inducible factor-1alpha protein stability by interacting with prolyl hydroxylases in gastric cancer cells", Oncogene, 33, pp.1458~1467 (2014)[DOI]
90. Zhou WN, "RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma", Oncol Rep, 38, pp.2378~2386 (2017)[DOI]
91. Bauer O, "Carcinogen-induced skin tumor development requires leukocytic expression of the transcription factor Runx3", Cancer Pre Res (Phila), 7, pp.913~926 (2014)[DOI]
92. Brenner O, "Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia", Proc Nat Acad Sci U S A, 101, pp.16016~16021 (2004)[DOI]
93. Fainaru O, "Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation", EMBO J, 23, pp.969~979 (2004)[DOI]
94. Naoe Y, "Repression of interleukin-4 in T helper type 1 cells by Runx", Cbf beta binding to the Il4 silencer, 2007, pp.204, 1749~1755
95. Fan L, "MicroRNA-145 influences the balance of Th1", Th2 via regulating RUNX3 in asthma patients, 2016, pp.42, 417~424
96. Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)[DOI]

관련 논문AI추천